The role of fibrinolysis in the era of primary percutaneous coronary intervention.
Department of Cardiology, Oslo University Hospital, Oslo, Norway. sigrun.h@online.no
Sigrun
S
Halvorsen
Kurt
K
Huber
D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D001241:Aspirin / Q000494:pharmacology; D006328:Cardiac Catheterization / Q000379:methods; D002309:Cardiology / Q000379:methods; D005260:Female; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D008297:Male; D008954:Models, Biological; D009203:Myocardial Infarction / Q000473:pathology / Q000628:therapy*; D012306:Risk; D015912:Thrombolytic Therapy / Q000379:methods; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000378:metabolism
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D001241:Aspirin